Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels
Open Access
- 27 May 1999
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (21), 1623-1629
- https://doi.org/10.1056/nejm199905273402103
Abstract
In patients with refractory unstable angina, the platelet glycoprotein IIb/IIIa–receptor antibody abciximab reduces the incidence of cardiac events before and during coronary angioplasty. We investigated whether serum troponin T levels identify patients most likely to benefit from therapy with this drug.Keywords
This publication has 22 references indexed in Scilit:
- Applicability of Cardiac Troponin T and I for Early Risk Stratification in Unstable Coronary Artery DiseaseCirculation, 1997
- Troponin T Identifies Patients With Unstable Coronary Artery Disease Who Benefit From Long-Term Antithrombotic ProtectionJournal of the American College of Cardiology, 1997
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Prognostic Significance of Admission Troponin T Concentrations in Patients With Myocardial InfarctionCirculation, 1996
- Prognostic value of cardiac troponin T in unstable angina pectorisThe American Journal of Cardiology, 1995
- Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarctionJournal of the American College of Cardiology, 1995
- The Prognostic Value of Serum Troponin T in Unstable AnginaNew England Journal of Medicine, 1992
- Unstable angina. A classification.Circulation, 1989
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985